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Using antibodies generated to the C-terminal 63 amino acids of the cloned rat 
mu receptor, the present study examines the distribution of the mu receptor- 
like immunoreactivity (li) in perfused rat brain sections. Generally, the 
localization of the mu receptor-li compares well with previous receptor 
binding studies, with staining observed in such regions as the caudate- 
putamen, nucleus accumbens, hippocampus, amygdala, thalamus, superior 
and inferior colliculi, interpeduncular nucleus, parabrachial nucleus, locus 
coeruleus, raphe nuclei, nucleus tractus solitarius, and the dorsal horn of the 
spinal cord. This distribution is consistent with the broad number of 
functions associated with mu receptors, including inhibition of sensory 
transmission and the regulation of neuroendocrine and neurotransmitter 
release. 
The mu receptor is one of three opioid receptor types localized in the central nervous 
system. Together with the other opioid receptor types, delta and kappa, these receptors 
play important modulatory roles in the control of neurotransmitter release, pain regula- 
tion and neuroendocrine control. The recent cloning of the mu opioid receptor (1,2) has 
allowed the visualization of the receptor, not only in terms of its binding sites, but also 
in terms of the mRNA encoding this receptor with in situ hybridization techniques (3,4). 
In addition, specific antibodies can be generated to the deduced protein sequences of 
the cloned receptor to directly visualize the mu receptor protein using immunohisto- 
chemical techniques. The present study examines the immunohistochemical localiza- 
tion of the mu opioid receptor protein in perfused rat brain sections and provides a 
better understanding of the cells and fibers expressing these receptors in the rat CNS. 
Antibody Production. A 228 bp fragment (1175-1403) of the rat mu receptor (2) 
was subcloned into the pGEX-kg protein expression vector (5). This plasmid, when 
expressed in bacteria (JM101), produces a glutathione S-transferase (GST)-mu receptor 
fusion protein which can be purified from crude bacterial extracts using glutathione 
affinity chromatography (6). The portion of the mu receptor that is expressed with this 
construct corresponds to the C-terminal 63 amino acids of the rat mu receptor, a region 
which shows little amino acid homology to the cloned delta and kappa receptors (7,8). 
Antibodies were generated by inoculating rabbits (New Zealand White) with 250 ~tg of 
the mu receptor-fusion protein suspended in Freund's adjuvant using a standard 
injection schedule. The resulting rabbit serum was affinity purified using the C- 
terminal 63 amino acid mu receptor protein coupled to a sepharose-4B-cyanogen 
bromide column. 
Immunohistochemistry. Male Sprague-Dawley rats (n = 4) were perfused 
transcardially with 0.9% saline followed by Zamboni's fixative. Brains were removed 
from the calvaria, posffixed in Zamboni's fixative (24 h), sectioned on a Jung microtome 
(30 ~t) and immunohistochemically stained using standard methods (9). Floating 
sections were washed in 50 mM KPBS, incubated with 0.3% H202 (30 min), rinsed in 50 
mM KPBS and incubated for 48 h with the mu receptor antibody (1:1000, diluted in 50 
mM KPBS, 0.4% Triton, 1% BSA, 1% normal goat serum) at 4°C. After washing with 50 
mM KPBS, sections were incubated with biotinylated goat anti-rabbit (1:200, 1 h, 22°C), 
followed by an avidin-biotin complex coupled to HRP (1:200, 1 h, 22°C, Vector Elite). 
The HRP reaction product was visualized by DAB with nickel chloride enhancement. 
Immunohistochemical controls included the co-incubation of the mu antibody with an 
excess of the mu receptor-fusion protein (4 ~tM). 
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Figure 1. Mu receptor immunohistochemical staining in the caudate-putamen 
(A). Mu receptor staining is most dense in the striatal patches and subcallosal 
streak that are indicated by arrows. In addition, scattered cells and fibers are 
seen in the striatal matrix. Size bar = 200 ~m. 
The distribution of the mu receptor immunoreactivity is consistent with previous 
receptor binding and in situ hybridization studies (3). Immunohistochemical staining 
was observed in regions including the caudate-putamen, nucleus accumbens, olfactory 
tubercle, lateral septum, medial preoptic area, bed nucleus of the stria terminalis, 
amygdala (intercalated nuclei, posteriocortical medial nucleus), hippocampus, thalamus 
(habenula, paraventricular nucleus, medial geniculate body), superior and inferior 
colliculi, interpeduncular nucleus, parabrachial nucleus, locus coeruleus, raphe nuclei 
(median, raphe magnus), pontine reticular nuclei, nucleus tractus solitarius, and in the 
superficial layers of the spinal cord. In the caudate-putamen, mu immunohistochemical 
staining is most dense in the striatal patches and subcallosal streak, with fewer fibers 
seen in the matrix compartment (Fig. 1). One region demonstrating dense mu 
immunohistochemical staining and little or no mu receptor binding is the external layer 
of the median eminence, where mu receptors may influence the release of anterior lobe 
hormones. 
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